Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.4%

2 terminated out of 27 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (9)
P 1 (5)
P 4 (2)

Trial Status

Completed12
Unknown5
Active Not Recruiting3
Recruiting2
Terminated2
Not Yet Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT06458998Not ApplicableEnrolling By InvitationPrimary

Getting To Implementation: Improving Cancer Screening for Veterans

NCT04258813Not ApplicableActive Not Recruiting

Onco-primary Care Networking to Support TEAM-based Care

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT04348838RecruitingPrimary

Prospective Cohort of Patients With Hepatocellular Carcinoma in France

NCT05179824Active Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT05041335Not ApplicableNot Yet Recruiting

Wet Heparinized Suction for Abdominal Cancer

NCT03133286Completed

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

NCT05109052Phase 1Withdrawn

Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma

NCT03347162Active Not Recruiting

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

NCT05907772CompletedPrimary

Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma

NCT05030090Not ApplicableCompleted

Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer

NCT05643833CompletedPrimary

Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma

NCT04172714Not ApplicableCompleted

Low-dose Y90 Treatment Planning for HCC

NCT01657383CompletedPrimary

Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery

NCT03896958Unknown

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

NCT02145559Phase 1Completed

A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

NCT03766776Not ApplicableUnknownPrimary

Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

NCT03299036Not ApplicableCompletedPrimary

Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy

NCT02825550Not ApplicableCompletedPrimary

Taiwan ACE Beads for Hepatoma Embolization Therapy

NCT03607643Phase 1Unknown

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Scroll to load more

Research Network

Activity Timeline